Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2011 | 09-2011 | 03-2011 | 03-2010 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 4,476,770 | 4,471,280 | N/A |
| Depreciation Amortization | N/A | N/A | 11,325,800 | 1,234,670 | N/A |
| Other Working Capital | N/A | N/A | -110,360 | 152,120 | N/A |
| Other Operating Activity | 0 | 0 | -11,753,200 | -1,759,490 | 0 |
| Operating Cash Flow | $N/A | $N/A | $3,939,010 | $4,098,580 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,487,650 | -926,950 | N/A |
| Net Acquisitions | N/A | N/A | 0 | -74,000 | N/A |
| Other Investing Activity | 0 | 0 | 291,810 | -262,710 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-1,195,840 | $-1,263,660 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -1,711,500 | -1,543,590 | N/A |
| Other Financing Activity | 0 | 0 | -54,090 | -48,300 | 0 |
| Financing Cash Flow | $N/A | $N/A | $-1,765,590 | $-1,591,890 | $N/A |
| Exchange Rate Effect | N/A | N/A | -733,840 | -227,980 | N/A |
| Beginning Cash Position | N/A | N/A | 10,270,840 | 8,151,410 | N/A |
| End Cash Position | N/A | N/A | 10,514,570 | 9,166,450 | N/A |
| Net Cash Flow | $N/A | $N/A | $243,730 | $1,015,030 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 3,939,010 | 4,098,580 | N/A |
| Free Cash Flow | 0 | 0 | 3,939,010 | 4,098,580 | 0 |